FFO
BIOA

Fortitude Family Office’s BioAge Labs BIOA Stock Holding History

Fortitude Family Office’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472 Sell
27
-93
-78% -$1.79K ﹤0.01% 1751
2025
Q4 		$1.59K Hold
120
– – ﹤0.01% 1270
2025
Q3 		$706 Buy
+120
New +$562 ﹤0.01% 1673

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Fortitude Family Office's BIOA Position: Q1 2026 in Review

Fortitude Family Office reduced its BioAge Labs (BIOA) stake by 78% in Q1 2026, selling an estimated $1.79K and leaving 27 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Fortitude Family Office first reported a position in BIOA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.59K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Fortitude Family Office held 27 shares of BioAge Labs worth $472 as of Q1 2026.
  • Fortitude Family Office sold 93 BioAge Labs shares in Q1 2026, an estimated $1.79K.
  • BioAge Labs made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1751 holding.
  • Fortitude Family Office first reported a position in BioAge Labs in Q3 2025 and has held it in 3 quarters since.
  • Fortitude Family Office's BioAge Labs position peaked at $1.59K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.